<?xml version="1.0" encoding="UTF-8"?>
<p>A current pandemic outbreak of Coronavirus diseases-2019 (COVID-19) has affected 216 countries and territories and more than 47 million cases were reported till 3 November 2020 (
 <uri xlink:href="https://www.worldometers.info/coronavirus/" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.worldometers.info/coronavirus/</uri>). Along with the research on the development of vaccines and antiviral drugs, many researchers are also focusing on the plant-derived natural products as potential sources of therapeutic agents. According to Clinical Trials Registry-India [
 <xref rid="B12-medicines-07-00069" ref-type="bibr">12</xref>], an open label, randomized, comparative, multi-center, parallel group, controlled clinical study has been started in India to evaluate the effect and safety of aqueous extract of 
 <italic>Cocculus hirsutus</italic> (AQCH) tablets in treatment of Coronavirus infection (CTRI Number: CTRI/2020/05/025397, registered on 28 May 2020). Previously, a randomized, Phase-I, double-blind, placebo-controlled, dose-escalation study to evaluate safety and tolerability of AQCH tablets in healthy adult human subjects was registered (CTRI Number: CTRI/2019/12/022297, registered on 10 December 2019). To the best of our knowledge, the outcomes of these studies have not been published yet. 
</p>
